[Omeprazole in H2-receptor blockader-refractory sclerosing ulcers of the esophagus].
Jaspersen
D
D
Körner
T
T
Schorr
W
W
Hammar
C H
CH
D004940:Esophageal Stenosis / Q000188:drug therapy* / Q000209:etiology; D004932:Esophageal and Gastric Varices / Q000150:complications / Q000628:therapy; D006801:Humans; D009853:Omeprazole / Q000627:therapeutic use*; D000077423:Polidocanol; D011092:Polyethylene Glycols / Q000009:adverse effects; D012597:Sclerosing Solutions / Q000009:adverse effects; D015911:Sclerotherapy / Q000009:adverse effects; D014456:Ulcer / Q000188:drug therapy / Q000209:etiology
D012597:Sclerosing Solutions; D000077423:Polidocanol; D011092:Polyethylene Glycols; D009853:Omeprazole
Omeprazol bei H2-Rezeptorenblocker-refraktären Sklerosierungsulcera des Osophagus.